Related Experiment Video

Updated: Jul 9, 2026

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1

V L Franklin1, F Khan, G Kennedy

  • 1Maternal and Child Health Sciences, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK. victoria.franklin@nhs.net

Diabetologia
|November 28, 2007
PubMed

Insights

Intensive insulin therapy (IIT) improved endothelial function and vascular markers in children with type 1 diabetes. This vascular protection occurred independently of glycemic control changes, suggesting additional benefits beyond blood sugar management.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health in Diabetes
  • Vascular Biology

Background:

  • Macrovascular disease is a major complication in type 1 diabetes, starting in childhood.
  • Vascular impairment in type 1 diabetes contributes to increased morbidity and mortality.
  • Early intervention is crucial for managing long-term diabetic complications.

Purpose of the Study:

  • To evaluate the impact of intensive diabetes management on endothelial function in children with type 1 diabetes.
  • To assess if intensive insulin therapy (IIT) combined with 'Sweet Talk' support improves vascular health.
  • To determine the effects of IIT versus conventional insulin therapy (CIT) on endothelial markers.

Main Methods:

  • A randomized controlled trial involving 92 children (8-18 years) with type 1 diabetes.
  • Participants were assigned to: CIT only, CIT with 'Sweet Talk', or IIT with 'Sweet Talk'.
  • Vascular assessments and HbA1c levels were measured at baseline and after 12 months.

Main Results:

  • Glycemic control worsened with CIT but improved significantly with IIT (p=0.007).
  • IIT showed greater improvements in E-selectin (p<0.0001) compared to CIT.
  • Vascular responses to acetylcholine improved with IIT (p=0.017), independent of HbA1c.

Conclusions:

  • Intensive insulin therapy (IIT) demonstrates potential for conferring vascular protection in type 1 diabetes.
  • Improvements in vascular markers with IIT occur independently of HbA1c levels.
  • IIT may offer dual benefits: improved glycemic control and direct vascular health advantages.
Abstract

More Related Videos

Non-invasive Assessment of Microvascular and Endothelial Function05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

Assessing Endothelial Vasodilator Function with the Endo-PAT 200007:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.